COVID-19 vaccine delivery and distribution statement from MD Anderson
The University of Texas MD Anderson Cancer Center is prepared to accept, store and distribute the Pfizer COVID-19 vaccine following the Food and Drug Administration’s decision on Friday, Dec. 11, to grant Emergency Use Authorization. At present, state and local health officials have allocated 4,875 doses of vaccine in the first shipment to MD Anderson for use with frontline health care workers, which is scheduled for delivery on...
Novel antibody-drug conjugate shows promising early results in rare blood cancer
ABSTRACT 167
A phase I/II study led by researchers from The University of Texas MD Anderson Cancer Center found IMGN632, a novel CD123...
Stereotactic radiosurgery recommended for patients with more than three brain metastases
Researchers from The University of Texas MD Anderson Cancer Center have conducted the first randomized clinical trial comparing stereotactic...
Lung cancer screening decision aid delivered through tobacco quitlines improves informed decision-making
In the first comparative clinical trial of lung cancer screening decision aid versus standard educational information, researchers from The University of Texas MD Anderson Cancer Center have shown that a decision aid delivered through tobacco quitlines effectively reaches a screening-eligible population and results in informed decisions about lung cancer screening.
Lung cancer is the second most common cancer diagnosis among adults...
